Senator Blunt inquires about user fees for generics.
03/16/2011
https://www.congress.gov...
I appreciate the work we have done together. As you said, this is in my, in all likelihood, last NIH hearing.
I think there is some discussion where they may graduate in some way to where they continue to exist.
I am asking that, or if there should be some 'new normal' approval process, now that we have had, I think two vaccines, ...
I want to say to that, Secretary, there is a reason that we had the veterans set aside in some of these areas.